Sofinnova Investments, Inc. Clearside Biomedical, Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.0 - $6.12 $606,914 - $3.71 Million	-606,914 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$6.03 - $11.24 $1.05 Million - $1.96 Million	174,010 Added 40.2%	606,914 $3.73 Million
Q2 2018 Nov 15, 2018	BUY	$8.91 - $14.54 $3.46 Million - $5.65 Million	388,284 Added 870.2%	432,904 $4.63 Million
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $82,337 - $134,364	9,241 Added 26.12%	44,620 $477,000
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $197,061 - $505,212	35,379 New	35,379 $380,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $60.8M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.